[Translation] A randomized, double-blind, placebo-controlled, single-dose and multiple-dose escalation phase I clinical trial was conducted to evaluate the safety, tolerability, and pharmacokinetic characteristics of ETD-001 gel in healthy Chinese subjects.
主要目的:评估ETD-001 在中国健康受试者中的安全性和耐受性。
次要目的:评估ETD-001 在中国健康受试者中的药代动力学特征。
[Translation] Primary objective: To evaluate the safety and tolerability of ETD-001 in healthy subjects in China.
Secondary objective: To evaluate the pharmacokinetic characteristics of ETD-001 in healthy subjects in China.